You don’t have products yet

View products

Omicsveu Unveils Revolutionary Technology: Visualization RNAveu Redefines Spatial Transcriptomics

FREMONT, CALIFORNIA, USA, January 3, 2024

Omicsveu driven to harness and accelerate multiplex multi-omics Spatial Biology research, proudly announces unveiling of an advanced technology – RNAveu that enables multiplexing of up to 40 RNA transcripts with single-gene sensitivity, and only two hybridization steps. Further, system is designed to colocalize DNA, RNA, mRNA, miRNA, and protein biomarkers.

RNAveu is a cutting-edge multiplexing technology that allows in situ localization of tumor-specific biomarkers to diagnose tumor heterogeneity and elucidate tumor microenvironment to improve characterization of tumor for better diagnostic and therapeutic modalities. Unlike traditional techniques that primarily focus on protein expression, RNAveu is designed to visualize a single copy gene with only two hybridization steps. Cocktail of multiple transcript-specific probes with DNA barcode on both 3’ and 5’ ends hybridize to specific sequences on target gene followed by hybridization of visualization probe on both ends with complimentary barcode sequences which are conjugated with 20 fluorophores. The RNAveu protocol provides reproducible, robust assay for distinct clean, intense signal for localization of single copy gene.

“RNAveu is a trailblazer in the realm of spatial transcriptomics, a field dedicated to understanding RNA expression in their native context within tissues. Its ability to uncover the cellular profiling of mRNA within cells is transforming our understanding of tumor biology, development, and diseases” said Dr. Krishan Kalra, CEO of Omicsveu.

Download RNAveu Brochure: http://bit.ly/RNAveu_Brochure

Trending Blog on RNAveu: https://bit.ly/RNAveu_Blog

Know more about RNAveu: https://omicsveu.com/rnaveu-products

About Omicsveu:
We deliver the most innovative and powerful biomedical tools that fuel Spatial Biology discoveries to meet other life science challenges of today. Our fully automated and integrated systems are affordable, simple, fast to accelerate precision oncology research, reduce cost, improve disease outcome, and enhance patient quality of life.

To learn more about Omicsveu, visit https://omicsveu.com/

For media inquiries, interviews, or further information, please contact:
48810 Kato Road,
Suite 100E & 200E, Fremont, CA 94538 USA
Tel: +1 510-824-1400
Email: customerservice@omicsveu.com

Share